{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:23:53Z","timestamp":1783052633433,"version":"3.54.6"},"reference-count":204,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["82270861"],"award-info":[{"award-number":["82270861"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2024YFC3308400"],"award-info":[{"award-number":["2024YFC3308400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>The recently conceptualized Cardiovascular\u2013Kidney\u2013Metabolic (CKM) syndrome represents a pressing global health burden, characterized by a vicious cycle of dysfunction among the cardiac, renal, and metabolic systems. Growing evidence suggests that gut microbiota dysbiosis, specifically, a loss of butyrate-producing bacteria (BPB) and the resulting systemic butyrate deficiency, may be an important but previously overlooked driver of CKM progression. In this review, we synthesize available evidence linking butyrate to the integrated, multi-organ pathophysiology of CKM and propose a conceptual framework we term the gut-butyrate-CKM axis. We discuss the multiple mechanisms by which butyrate and BPB exert protective effects, including targeting key pathophysiological features of CKM, such as insulin resistance (IR), metabolic inflammation, oxidative stress, endothelial dysfunction, renin\u2013angiotensin\u2013aldosterone system (RAAS) overactivation, and gut dysbiosis itself. Through a critical appraisal of human studies, we bring together findings from direct butyrate supplementation, dietary interventions, and microbiota-directed strategies. Based on this, we argue that butyrate serves as a central hub linking gut homeostasis to systemic metabolic and cardiorenal health. By integrating previously fragmented observations into a coherent framework, this review addresses a conceptual gap in our understanding of CKM pathogenesis and points to actionable, microbiota-targeted therapeutic strategies that could help break the disease cycle. Given the current lack of integrated management options for CKM, our work offers insights for future translational research and clinical practice, highlighting butyrate-centered approaches as a potential paradigm shift in CKM care.<\/jats:p>","DOI":"10.3390\/antiox15070812","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:01:17Z","timestamp":1782813677000},"page":"812","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Butyrate and Butyrate-Producing Bacteria in Cardiovascular\u2013Kidney\u2013Metabolic Syndrome"],"prefix":"10.3390","volume":"15","author":[{"given":"Wenli","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-0312","authenticated-orcid":false,"given":"Zhongchun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China"},{"name":"Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430060, China"},{"name":"State Key Laboratory of Metabolism and Regulation in Complex Organisms, Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-0433","authenticated-orcid":false,"given":"Ling","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Renmin Hospital of Wuhan University, Wuhan 430060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pcad.2024.10.012","article-title":"Cardiovascular-kidney-metabolic syndrome\u2014An integrative review","volume":"87","author":"Kittelson","year":"2024","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rahman, M.M., Islam, F., -Or-Rashid, M.H., Mamun, A.A., Rahaman, M.S., Islam, M.M., Meem, A.F.K., Sutradhar, P.R., Mitra, S., and Mimi, A.A. (2022). The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.903570"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hsu, C.N., Lin, Y.J., Hou, C.Y., Chen, Y.W., and Tain, Y.L. (2025). Early-Life Prevention of Cardiovascular-Kidney-Metabolic Syndrome: The DOHaD Perspective on Resveratrol and Short-Chain Fatty Acids. Antioxidants, 14.","DOI":"10.3390\/antiox14070851"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCRESAHA.125.326748","article-title":"Spatiotemporal Proliferative Heterogeneity of Intraorgan Endothelial Cells","volume":"137","author":"Han","year":"2025","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ni.1825","article-title":"Enteric defensins are essential regulators of intestinal microbial ecology","volume":"11","author":"Salzman","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"115420","DOI":"10.1016\/j.foodres.2024.115420","article-title":"Butyrate: A potential mediator of obesity and microbiome via different mechanisms of actions","volume":"199","author":"Arslan","year":"2025","journal-title":"Food Res. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2467193","DOI":"10.1080\/19490976.2025.2467193","article-title":"Roseburia hominis improves host metabolism in diet-induced obesity","volume":"17","author":"Huang","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1111\/jgh.15487","article-title":"Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease","volume":"36","author":"Iwaki","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","article-title":"A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression","volume":"109","author":"Jiang","year":"2016","journal-title":"Antonie Leeuwenhoek"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sanchez-Alcoholado, L., Castellano-Castillo, D., Jord\u00e1n-Mart\u00ednez, L., Moreno-Indias, I., Cardila-Cruz, P., Elena, D., Mu\u00f1oz-Garcia, A.J., Queipo-Ortu\u00f1o, M.I., and Jimenez-Navarro, M. (2017). Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.01936"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1053\/j.gastro.2021.06.056","article-title":"Alterations in the Gut Virome in Obesity and Type 2 Diabetes Mellitus","volume":"161","author":"Yang","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: Global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","article-title":"Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages Among Middle-Aged and Older Adults in China","volume":"5","author":"Zhang","year":"2025","journal-title":"JACC Asia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA"},{"key":"ref_16","first-page":"859","article-title":"Study on Accounting and Analysis of Curative Expenditure on Cardio-cerebrovascular Diseases in China","volume":"35","author":"Zhang","year":"2017","journal-title":"Zhongguo Xunhuan Zazhi (Chin. Circ. J.)"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"(2023). Correction to: Heart Disease and Stroke Statistics-2023 Update: A Report from the American Heart Association. Circulation, 148, e4.","DOI":"10.1161\/CIR.0000000000001167"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.0000000637","article-title":"Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome","volume":"36","author":"Claudel","year":"2025","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102344","DOI":"10.1016\/j.cpcardiol.2023.102344","article-title":"Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Li, Y., Luo, Z., Zhang, Z., Huang, N., Xiao, L., and Zou, K. (2025). Socioeconomic status, depressive symptoms and cardiometabolic kidney syndrome: An analysis based on national representative data. BMC Public Health, 25.","DOI":"10.1186\/s12889-025-25228-0"},{"key":"ref_22","first-page":"e94134","article-title":"Cardio-Renal Metabolic Syndrome: An Integrated Approach to Prevention and Management","volume":"17","author":"Singh","year":"2025","journal-title":"Cureus"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xiao, Y., You, H., Wang, T., Zeng, Y., Zhu, Y., Zhang, R., Liu, D., Zhao, Y., Liu, Y., and You, S. (2026). Mediating effect of insulin resistance in the relationship between dietary inflammatory index and cardiovascular-kidney-metabolic syndrome stage in US adults, 2007-2018. Food Nutr. Res., 70.","DOI":"10.29219\/fnr.v70.13744"},{"key":"ref_24","first-page":"e85813","article-title":"Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology and Integrated Management Approach","volume":"17","year":"2025","journal-title":"Cureus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/ATVBAHA.111.241919","article-title":"Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease","volume":"32","author":"Kahn","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1253\/circj.CJ-17-0458","article-title":"Role of Adipokines in Cardiovascular Disease","volume":"81","author":"Lau","year":"2017","journal-title":"Circ. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12944-023-01847-7","article-title":"Adipose tissue dysfunction serum markers are associated with high density lipoprotein size and glycation in the early stages of type 2 diabetes","volume":"22","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cytogfr.2025.08.001","article-title":"Neuro-endocrine-immune regulation of metabolic homeostasis","volume":"85","author":"Xie","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0025-7125(03)00128-7","article-title":"Insulin and insulin resistance: Impact on blood pressure and cardiovascular disease","volume":"88","author":"Sowers","year":"2004","journal-title":"Med. Clin. N. Am."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1992.400","article-title":"Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats","volume":"42","author":"Tucker","year":"1992","journal-title":"Kidney Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0167-0115(98)00156-6","article-title":"Relaxing effect of insulin in renal arteries from diabetic rats","volume":"79","author":"Torffvit","year":"1999","journal-title":"Regul. Pept."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2337\/dc19-1651","article-title":"Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults with Type 2 Diabetes and Preserved Renal Function","volume":"43","author":"Ruiter","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000093632","article-title":"Insulin resistance, hyperinsulinemia, and renal injury: Mechanisms and implications","volume":"26","author":"Sarafidis","year":"2006","journal-title":"Am. J. Nephrol."},{"key":"ref_35","first-page":"671","article-title":"Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited","volume":"36","author":"Li","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_36","first-page":"41","article-title":"Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from that of Diabetes or Obesity?","volume":"8","author":"Sowers","year":"2017","journal-title":"Cardiorenal Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/17446651.2022.2131534","article-title":"Renal insulin resistance in type 2 diabetes mellitus and progression of chronic kidney disease: Potential pathogenic mechanisms","volume":"17","author":"Alqallaf","year":"2022","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Nzobokela, J., Muchaili, L., Mwambungu, A., Masenga, S.K., and Kirabo, A. (2025). Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1661563"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mozos, I., Malainer, C., Horba\u0144czuk, J., Gug, C., Stoian, D., Luca, C.T., and Atanasov, A.G. (2017). Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01058"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102282","DOI":"10.1016\/j.molmet.2025.102282","article-title":"NLRP3 inhibition by VTX3232 tempers inflammation resulting in reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice","volume":"103","author":"Bultinck","year":"2026","journal-title":"Mol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e949030","DOI":"10.12659\/MSM.949030","article-title":"Signaling Pathways and Therapeutic Approaches in Post-Myocardial Infarction Fibrosis","volume":"31","author":"Ba","year":"2025","journal-title":"Med. Sci. Monit."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI96139","article-title":"Insulin resistance causes inflammation in adipose tissue","volume":"128","author":"Shimobayashi","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ciortan, L., Macarie, R.D., Barbu, E., Naie, M.L., Mihaila, A.C., Serbanescu, M., and Butoi, E. (2025). Cross-Talk Between Neutrophils and Macrophages Post-Myocardial Infarction: From Inflammatory Drivers to Therapeutic Targets. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110575"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11883-025-01324-9","article-title":"Anti-Atherogenic Mechanisms and Therapies","volume":"27","author":"Hudson","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_45","first-page":"523","article-title":"The role of cardiac fat in insulin resistance","volume":"15","author":"Gastaldelli","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1523-1755.2004.00900.x","article-title":"TNF-\u03b1 and IL-1\u03b2-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells","volume":"66","author":"Nee","year":"2004","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.123.001621","article-title":"The CaMKII Inhibitory Peptide AIP Alleviates Renal Fibrosis Through the TGF-\u03b2\/Smad and RAF\/ERK Pathways","volume":"386","author":"Feng","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1159\/000065451","article-title":"Interleukin 4 co-stimulates the PDGF-BB- and bFGF-mediated proliferation of mesangial cells and myofibroblasts","volume":"92","author":"Sommer","year":"2002","journal-title":"Nephron"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.arplant.55.031903.141701","article-title":"Reactive oxygen species: Metabolism, oxidative stress, and signal transduction","volume":"55","author":"Apel","year":"2004","journal-title":"Annu. Rev. Plant Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s40124-025-00371-9","article-title":"Cardiovascular-Kidney-Metabolic Syndrome\u2014What can be Done in Childhood?","volume":"13","year":"2025","journal-title":"Curr. Pediatr. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Kulovic-Sissawo, A., Tocantins, C., Diniz, M.S., Weiss, E., Steiner, A., Tokic, S., Madreiter-Sokolowski, C.T., Pereira, S.P., and Hiden, U. (2024). Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells. Biology, 13.","DOI":"10.3390\/biology13020070"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00394-016-1212-2","article-title":"Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders","volume":"55","author":"Stefano","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.bbrc.2009.10.066","article-title":"Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose","volume":"390","author":"Toma","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/jpdtsm.jpdtsm_21_25","article-title":"Oxidative Stress and Related Diseases: A Comprehensive Review","volume":"4","year":"2025","journal-title":"J. Prev. Diagn. Treat. Strateg. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bj.2017.06.007","article-title":"The etiology of oxidative stress in insulin resistance","volume":"40","author":"Hurrle","year":"2017","journal-title":"Biomed. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10741-011-9228-4","article-title":"Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: Potential therapeutic strategies","volume":"17","author":"Tousoulis","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/j.1523-1755.2005.00674.x","article-title":"Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension","volume":"68","author":"Stewart","year":"2005","journal-title":"Kidney Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tcb.2020.10.003","article-title":"The Endothelium: An Active Regulator of Lipid and Glucose Homeostasis","volume":"31","author":"Hasan","year":"2021","journal-title":"Trends Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103760","DOI":"10.1016\/j.redox.2025.103760","article-title":"Obesity-induced arterial redox imbalance involving mitochondrial NOX4, endothelial dysfunction, and ER stress underlie kidney injury compensated by enhanced mitochondrial bioenergetics","volume":"85","author":"Contreras","year":"2025","journal-title":"Redox Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"115236","DOI":"10.1016\/j.intimp.2025.115236","article-title":"NEK7 mediates ESRD-associated endothelial injury by activating the NLRP3 inflammasome","volume":"163","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00391.2014","article-title":"Modulation of glucose metabolism by the renin-angiotensin-aldosterone system","volume":"308","author":"Favre","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Porter, C.S., Brown, L.T., Lacey, C., Hickel, M.T., and Stewart, J.A. (2025). Knocking Out Rap1a Attenuates Cardiac Remodeling and Fibrosis in a Male Murine Model of Angiotensin II-Induced Hypertension. Cells, 14.","DOI":"10.3390\/cells14221834"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ajh\/hpx156","article-title":"Systemic Angiotensinogen Concentrations Are Independently Associated with Left Ventricular Diastolic Function in a Community Sample","volume":"31","author":"Millen","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91\u201392","author":"AlQudah","year":"2020","journal-title":"Matrix Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00000441-200307000-00003","article-title":"The renin-angiotensin-aldosterone system: Cardiorenal effects and implications for renal and cardiovascular disease states","volume":"326","author":"Brewster","year":"2003","journal-title":"Am. J. Med. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"156862","DOI":"10.1016\/j.phymed.2025.156862","article-title":"Lingguizhugan decoction ameliorates renal injury secondary to heart failure by improving pyroptosis through TLR4\/NF-KB\/IRE1\u03b1 pathway","volume":"143","author":"Lv","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s11427-024-2826-5","article-title":"High-fat diet-induced obesity-related hypertension via altered gut microbiota-mediated histone butyrylation","volume":"69","author":"Wang","year":"2026","journal-title":"Sci. China Life Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.chom.2025.08.014","article-title":"Gut-microbiota-derived indole sulfate promotes heart failure in chronic kidney disease","volume":"33","author":"Zhang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10715762.2017.1296575","article-title":"Indoxyl sulfate potentiates endothelial dysfunction via reciprocal role for reactive oxygen species and RhoA\/ROCK signaling in 5\/6 nephrectomized rats","volume":"51","author":"Chu","year":"2017","journal-title":"Free Radic. Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Duttaroy, A.K. (2021). Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review. Nutrients, 13.","DOI":"10.3390\/nu13010144"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e009972","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","article-title":"Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure","volume":"16","author":"Romano","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"bvz039","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1001275","DOI":"10.37349\/emed.2025.1001275","article-title":"Gut microbiota-derived metabolites and chronic inflammatory diseases","volume":"6","author":"Vargas","year":"2025","journal-title":"Explor. Med."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Bautista, J., and L\u00f3pez-Cort\u00e9s, A. (2025). Chronobiome medicine: Circadian regulation of host-microbiota crosstalk in systemic physiology. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1691172"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2532703","DOI":"10.1080\/19490976.2025.2532703","article-title":"Circadian rhythms of gut microbiota and plaque vulnerability: Mechanisms and chrono-microbiota modulation interventions","volume":"17","author":"Zhai","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Milazzo, G., Mercatelli, D., Di Muzio, G., Triboli, L., De Rosa, P., Perini, G., and Giorgi, F.M. (2020). Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. Genes, 11.","DOI":"10.3390\/genes11050556"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/138945006776359467","article-title":"Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane","volume":"7","author":"Myzak","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/msb.2013.33","article-title":"The HDAC interaction network","volume":"9","author":"Livyatan","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2485S","DOI":"10.1093\/jn\/133.7.2485S","article-title":"Inhibition of histone deacetylase activity by butyrate","volume":"133","author":"Davie","year":"2003","journal-title":"J. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"F133","DOI":"10.1152\/ajprenal.00400.2009","article-title":"Histone deacetylase modulates the proinflammatory and-fibrotic changes in tubulointerstitial injury","volume":"298","author":"Marumo","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semnephrol.2020.01.005","article-title":"Histone Deacetylases in Kidney Physiology and Acute Kidney Injury","volume":"40","author":"Hyndman","year":"2020","journal-title":"Semin. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/db11-0846","article-title":"Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3","volume":"61","author":"Li","year":"2012","journal-title":"Diabetes"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1111\/jcmm.14684","article-title":"Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2\/PGE2 pathway via a HDAC5\/HDAC6-dependent mechanism","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Pant, K., Richard, S., and Gradilone, S.A. (2022). Short-Chain Fatty Acid Butyrate Induces Cilia Formation and Potentiates the Effects of HDAC6 Inhibitors in Cholangiocarcinoma Cells. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.809382"},{"key":"ref_90","first-page":"1038","article-title":"Effect of sodium butyrate on HDAC8 mRNA expression in colorectal cancer cell lines and molecular docking study of LHX1-sodium butyrate interaction","volume":"19","author":"Forouzesh","year":"2020","journal-title":"EXCLI J."},{"key":"ref_91","first-page":"3941","article-title":"Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR\/S6K1 signaling mediated partly by SIRT1 downregulation","volume":"19","author":"Cao","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"109155","DOI":"10.1016\/j.jnutbio.2022.109155","article-title":"Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1\/mTOR in mice","volume":"111","author":"Wang","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/sigtrans.2016.35","article-title":"Butyrate induces apoptosis by activating PDC and inhibiting complex I through SIRT3 inactivation","volume":"2","author":"Xu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/epi.15.20","article-title":"The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: Experimental evidence for therapeutic intervention","volume":"7","author":"Khan","year":"2015","journal-title":"Epigenomics"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.freeradbiomed.2020.01.016","article-title":"Butyrate alleviates oxidative stress by regulating NRF2 nuclear accumulation and H3K9\/14 acetylation via GPR109A in bovine mammary epithelial cells and mammary glands","volume":"152","author":"Guo","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Geng, H.W., Yin, F.Y., Zhang, Z.F., Gong, X., and Yang, Y. (2021). Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.634874"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e2200597","DOI":"10.1002\/mnfr.202200597","article-title":"Butyrate Attenuates Hepatic Steatosis Induced by a High-Fat and Fiber-Deficient Diet via the Hepatic GPR41\/43-CaMKII\/HDAC1-CREB Pathway","volume":"67","author":"Zheng","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114524002964","article-title":"Butyrate attenuates high-fat diet-induced glomerulopathy through GPR43-Sirt3 pathway","volume":"133","author":"Shi","year":"2025","journal-title":"Br. J. Nutr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/0271678X20910533","article-title":"Sodium butyrate attenuated neuronal apoptosis via GPR41\/G\u03b2\u03b3\/PI3K\/Akt pathway after MCAO in rats","volume":"41","author":"Zhou","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Nakajima, A., Nakatani, A., Hasegawa, S., Irie, J., Ozawa, K., Tsujimoto, G., Suganami, T., Itoh, H., and Kimura, I. (2017). The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179696"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Kimura, I., Inoue, D., Hirano, K., and Tsujimoto, G. (2014). The SCFA Receptor GPR43 and Energy Metabolism. Front. Endocrinol., 5.","DOI":"10.3389\/fendo.2014.00085"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","article-title":"GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon","volume":"69","author":"Thangaraju","year":"2009","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00403-018-1865-1","article-title":"Decreased expression of G-protein-coupled receptors GPR43 and GPR109a in psoriatic skin can be restored by topical application of sodium butyrate","volume":"310","author":"Krejner","year":"2018","journal-title":"Arch. Dermatol. Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Hu, S., Kuwabara, R., de Haan, B.J., Smink, A.M., and de Vos, P. (2020). Acetate and Butyrate Improve \u03b2-cell Metabolism and Mitochondrial Respiration under Oxidative Stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041542"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Robles-Vera, I., Toral, M., de la Visitaci\u00f3n, N., Aguilera-S\u00e1nchez, N., Redondo, J.M., and Duarte, J. (2020). Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00277"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrmicro2546","article-title":"Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis","volume":"9","author":"Bevins","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Takakuwa, A., Nakamura, K., Kikuchi, M., Sugimoto, R., Ohira, S., Yokoi, Y., and Ayabe, T. (2019). Butyric Acid and Leucine Induce \u03b1-Defensin Secretion from Small Intestinal Paneth Cells. Nutrients, 11.","DOI":"10.3390\/nu11112817"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bph.15693","article-title":"Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K\/Akt\/mTOR signals","volume":"179","author":"Tang","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jphs.2021.04.005","article-title":"Centrally administered butyrate improves gut barrier function, visceral sensation and septic lethality in rats","volume":"146","author":"Okumura","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2036.2011.04757.x","article-title":"Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: The effects of substrate concentration and carnitine on the \u03b2-oxidation pathway","volume":"34","author":"Geboes","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"111681","DOI":"10.1016\/j.celrep.2022.111681","article-title":"Commensal cow Roseburia reduces gut-dysbiosis-induced mastitis through inhibiting bacterial translocation by producing butyrate in mice","volume":"41","author":"Zhao","year":"2022","journal-title":"Cell Rep."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Usuda, H., Okamoto, T., and Wada, K. (2021). Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147613"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2672.1991.tb02739.x","article-title":"The control and consequences of bacterial fermentation in the human colon","volume":"70","author":"Cummings","year":"1991","journal-title":"J. Appl. Bacteriol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0115426506021004351","article-title":"Short-chain fatty acids: Ready for prime time?","volume":"21","author":"Roy","year":"2006","journal-title":"Nutr. Clin. Pract."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AEM.02340-06","article-title":"Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces","volume":"73","author":"Duncan","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"eaat9076","DOI":"10.1126\/science.aat9076","article-title":"Colonocyte metabolism shapes the gut microbiota","volume":"362","author":"Litvak","year":"2018","journal-title":"Science"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/obr.12068","article-title":"Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?","volume":"14","author":"Brahe","year":"2013","journal-title":"Obes. Rev."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J. Nutr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","article-title":"Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function","volume":"17","author":"Kelly","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"104947","DOI":"10.1016\/j.phrs.2020.104947","article-title":"Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease","volume":"159","author":"Couto","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","article-title":"Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis","volume":"131","author":"Li","year":"2022","journal-title":"Circ. Res."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Han, Y., Zhao, Q., Tang, C., Li, Y., Zhang, K., Li, F., and Zhang, J. (2020). Butyrate Mitigates Weanling Piglets from Lipopolysaccharide-Induced Colitis by Regulating Microbiota and Energy Metabolism of the Gut-Liver Axis. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.588666"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jn\/nxy324","article-title":"Supplementation with Sodium Butyrate Modulates the Composition of the Gut Microbiota and Ameliorates High-Fat Diet-Induced Obesity in Mice","volume":"149","author":"Fang","year":"2019","journal-title":"J. Nutr."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Mayorga-Ramos, A., Barba-Ostria, C., Simancas-Racines, D., and Guam\u00e1n, L.P. (2022). Protective role of butyrate in obesity and diabetes: New insights. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1067647"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"109090","DOI":"10.1016\/j.jnutbio.2022.109090","article-title":"Sodium butyrate modulates blood pressure and gut microbiota in maternal tryptophan-free diet-induced hypertension rat offspring","volume":"108","author":"Hsu","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e024763","DOI":"10.1161\/JAHA.121.024763","article-title":"Increases in Circulating and Fecal Butyrate are Associated with Reduced Blood Pressure and Hypertension: Results from the SPIRIT Trial","volume":"11","author":"Tilves","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ndt\/gfae118","article-title":"Propionate and butyrate counteract renal damage and progression to chronic kidney disease","volume":"40","author":"Saiz","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1042\/CS20190171","article-title":"Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"22385","DOI":"10.1038\/s41598-024-72909-8","article-title":"Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression","volume":"14","author":"Yang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"nzac107","DOI":"10.1093\/cdn\/nzac107","article-title":"The Intestinal Microbiota and Short-Chain Fatty Acids in Association with Advanced Metrics of Glycemia and Adiposity Among Young Adults with Type 1 Diabetes and Overweight or Obesity","volume":"6","author":"Igudesman","year":"2022","journal-title":"Curr. Dev. Nutr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/DMSO.S434499","article-title":"Butyrate and Propionate are Negatively Correlated with Obesity and Glucose Levels in Patients with Type 2 Diabetes and Obesity","volume":"17","author":"Zhang","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.116.07910","article-title":"Increased Systolic and Diastolic Blood Pressure Is Associated with Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy","volume":"68","author":"Barrett","year":"2016","journal-title":"Hypertension"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40168-019-0683-9","article-title":"Alterations in the gut microbiome and metabolism with coronary artery disease severity","volume":"7","author":"Liu","year":"2019","journal-title":"Microbiome"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1038\/s41598-020-63475-w","article-title":"Gut metagenomic and short chain fatty acids signature in hypertension: A cross-sectional study","volume":"10","author":"Gosalbes","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"393","DOI":"10.15403\/jgld-4779","article-title":"The Gut Microbiota Profile in Heart Failure Patients: A Systematic Review","volume":"32","author":"Simadibrata","year":"2023","journal-title":"J. Gastrointest. Liver Dis. JGLD"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"giz058","DOI":"10.1093\/gigascience\/giz058","article-title":"Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation","volume":"8","author":"Zuo","year":"2019","journal-title":"GigaScience"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2001936","DOI":"10.1002\/advs.202001936","article-title":"Alterations of the Human Gut Microbiome in Chronic Kidney Disease","volume":"7","author":"Ren","year":"2020","journal-title":"Adv. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2304157","DOI":"10.1080\/19490976.2024.2304157","article-title":"Disruption of gut barrier integrity and host-microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus","volume":"16","author":"Forlano","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Jin, L.T., and Xu, M.Z. (2023). Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1113643"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e00857-19","DOI":"10.1128\/mSystems.00857-19","article-title":"Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening","volume":"5","author":"Sanz","year":"2020","journal-title":"mSystems"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Doumatey, A.P., Adeyemo, A., Zhou, J., Lei, L., Adebamowo, S.N., Adebamowo, C., and Rotimi, C.N. (2020). Gut Microbiome Profiles Are Associated with Type 2 Diabetes in Urban Africans. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00063"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s40200-022-01068-2","article-title":"Similar bacterial signatures in the gut microbiota of type 1 and type 2 diabetes patients and its association with G protein-coupled receptor 41 and 43 gene expression","volume":"21","author":"Demirci","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_145","first-page":"207","article-title":"Correlation of gut dominant microbiota with hyperuricemia","volume":"52","author":"Ji","year":"2023","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Liang, M., Liu, J., Chen, W., He, Y., Kahaer, M., Li, R., Tian, T., Liu, Y., Bai, B., and Cui, Y. (2022). Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levels. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.925119"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Morales, C., Rojas, G., Rebolledo, C., Rojas-Herrera, M., Arias-Carrasco, R., Cuadros-Orellana, S., Maracaja-Coutinho, V., Saavedra, K., Leal, P., and Lanas, F. (2022). Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.943609"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e039759","DOI":"10.1161\/JAHA.124.039759","article-title":"Effect of Acute Gut Butyrate Delivery on Blood Pressure in Black Individuals with Hypertension: A Proof-of-Concept Randomized Controlled Study","volume":"14","author":"Hogue","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s44161-022-00197-4","article-title":"Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial","volume":"2","author":"Jama","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Fogacci, F., Giovannini, M., Di Micoli, V., Grandi, E., Borghi, C., and Cicero, A.F.G. (2024). Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients, 16.","DOI":"10.3390\/nu16152454"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Mitrovi\u0107, M., Stankovi\u0107 Popovi\u0107, V., Erceg, S., Peri\u0161i\u0107 Mitrovi\u0107, M., Dobrosavljevi\u0107, A., Stupar, A., Vukovi\u0107, P., Zlatkovi\u0107, D., and Svorcan, P. (2025). Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Subgroup Insights from an Interventional Study. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202504.0157.v1"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e2244912","DOI":"10.1001\/jamanetworkopen.2022.44912","article-title":"Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial","volume":"5","author":"Coppola","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41430-024-01512-x","article-title":"Expression of PGC-1\u03b1, PPAR-\u03b1 and UCP1 genes, metabolic and anthropometric factors in response to sodium butyrate supplementation in patients with obesity: A triple-blind, randomized placebo-controlled clinical trial","volume":"79","author":"Amiri","year":"2025","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-0043-119089","article-title":"Effect of Butyrate and Inulin Supplementation on Glycemic Status, Lipid Profile and Glucagon-like Peptide 1 Level in Patients with Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Trial","volume":"49","author":"Roshanravan","year":"2017","journal-title":"Horm. Metab. Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clnesp.2022.03.008","article-title":"The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients: A randomized triple-blind, placebo-controlled trial","volume":"49","author":"Khosravi","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/db24-610-P","article-title":"Effect of butyrate on GI signs, SIBO, and diabetes control\u2014Randomized, placebo-controlled study in patients with type 2 diabetes","volume":"73","author":"Panufnik","year":"2024","journal-title":"Diabetes"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"101076","DOI":"10.1016\/j.molmet.2020.101076","article-title":"Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome","volume":"42","author":"Hartstra","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"bvae163.821","DOI":"10.1210\/jendso\/bvae163.821","article-title":"8000 Intestinimonas Butyriciproducens as a New Preventive Therapy for Type 2 Diabetes: A Proof of Concept Randomized Controlled Trial","volume":"8","author":"Antoniotti","year":"2024","journal-title":"J. Endocr. Soc."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.62347\/DNIL9369","article-title":"Clostridium butyricum CGMCC 0313.1 improves clinical outcomes of metabolic syndrome in schizophrenic patients","volume":"17","author":"Song","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2504115","DOI":"10.1080\/19490976.2025.2504115","article-title":"Anaerobutyricum soehngenii improves glycemic control and other markers of cardio-metabolic health in adults at risk of type 2 diabetes","volume":"17","author":"Attaye","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"110455","DOI":"10.1016\/j.isci.2024.110455","article-title":"Oral Anaerobutyricum soehngenii augments glycemic control in type 2 diabetes","volume":"27","author":"Attaye","year":"2024","journal-title":"iScience"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14715\/cmb\/2021.67.5.9","article-title":"Effects of Clostridium butyricum Capsules Combined with Rosuvastatin on Intestinal Flora, Lipid Metabolism, Liver Function and Inflammation in NAFLD Patients","volume":"68","author":"Zhu","year":"2022","journal-title":"Cell. Mol. Biol."},{"key":"ref_163","unstructured":"(2021). Correction: Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol., 77, 1958\u20131959."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"102649","DOI":"10.1016\/j.ebiom.2020.102649","article-title":"The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions","volume":"52","author":"Andersen","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2226922","DOI":"10.1080\/19490976.2023.2226922","article-title":"Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies","volume":"15","author":"Koning","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: A systematic review and Meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Wang, W., Wang, L., Chen, J., Yang, X., Guo, Q., Zhang, Z., Liang, J., Gu, P., and Shao, J. (2025). The gut microbiome: A vital link to hyperuricemia, gout and acute flares?. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1643566"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Karoor, V., Strassheim, D., Sullivan, T., Verin, A., Umapathy, N.S., Dempsey, E.C., Frank, D.N., Stenmark, K.R., and Gerasimovskaya, E. (2021). The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189916"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3748\/wjg.v25.i17.2019","article-title":"Microbial metabolites in non-alcoholic fatty liver disease","volume":"25","author":"Zhou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/dom.70624","article-title":"Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways with Disease Progression","volume":"28","author":"Tsakiridis","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Mahalingam, S., Kharbanda, K.K., Casey, C.A., and Rasineni, K. (2026). Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum. Front. Pharmacol., 17.","DOI":"10.3389\/fphar.2026.1752204"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"155101","DOI":"10.1016\/j.cyto.2020.155101","article-title":"Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: A randomized, double-blind, placebo-controlled trial","volume":"131","author":"Roshanravan","year":"2020","journal-title":"Cytokine"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e00794-20","DOI":"10.1128\/mSphere.00794-20","article-title":"Fecal Short-Chain Fatty Acid Concentrations Increase in Newly Paired Male Marmosets (Callithrix jacchus)","volume":"5","author":"Zhu","year":"2020","journal-title":"mSphere"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1039\/D1FO03896F","article-title":"A randomised, double-blind, placebo-controlled trial of Bifidobacterium bifidum CCFM16 for manipulation of the gut microbiota and relief from chronic constipation","volume":"13","author":"Wang","year":"2022","journal-title":"Food Funct."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"McMurdie, P.J., Stoeva, M.K., Justice, N., Nemchek, M., Sieber, C.M.K., Tyagi, S., Gines, J., Skennerton, C.T., Souza, M., and Kolterman, O. (2022). Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes. BMC Microbiol., 22.","DOI":"10.1186\/s12866-021-02415-8"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12934-020-01350-z","article-title":"Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice","volume":"19","author":"Bai","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1039\/C9FO00604D","article-title":"Eurotium cristatum, a potential probiotic fungus from Fuzhuan brick tea, alleviated obesity in mice by modulating gut microbiota","volume":"10","author":"Kang","year":"2019","journal-title":"Food Funct."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","article-title":"Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: A 24-week, double-blind, randomised controlled trial","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1292\/jvms.19-0640","article-title":"Activation of butyrate-producing bacteria as well as bifidobacteria in the cat intestinal microbiota by the administration of 1-kestose, the smallest component of fructo-oligosaccharide","volume":"82","author":"Shinohara","year":"2020","journal-title":"J. Vet. Med. Sci."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1863133","article-title":"The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial","volume":"13","author":"Vijay","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3945\/jn.110.128504","article-title":"Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch","volume":"141","author":"McOrist","year":"2011","journal-title":"J. Nutr."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1007\/s13197-015-1921-1","article-title":"Probiotics, prebiotics and synbiotics\u2014A review","volume":"52","author":"Pandey","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.clnu.2020.05.025","article-title":"Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: Can SCFAs play a role?","volume":"40","author":"Vitale","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1249\/MSS.0000000000001760","article-title":"Does Exercise Alter Gut Microbial Composition? A Systematic Review","volume":"51","author":"Mitchell","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_186","first-page":"629","article-title":"Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors","volume":"4","author":"Conley","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/jn\/131.6.1839","article-title":"Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells","volume":"131","author":"Gaschott","year":"2001","journal-title":"J. Nutr."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jn\/127.5.717","article-title":"Acarbose enhances human colonic butyrate production","volume":"127","author":"Weaver","year":"1997","journal-title":"J. Nutr."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12275-018-8297-7","article-title":"Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer\u2019s disease","volume":"56","author":"Nguyen","year":"2018","journal-title":"J. Microbiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1753-0407.12986","article-title":"Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression","volume":"12","author":"Xu","year":"2020","journal-title":"J. Diabetes"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","article-title":"Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease","volume":"65","author":"Maubert","year":"2016","journal-title":"Gut"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/s12967-022-03631-0","article-title":"The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure-the current facts and evidence","volume":"20","author":"Lakshmanan","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Engels, C., Ruscheweyh, H.J., Beerenwinkel, N., Lacroix, C., and Schwab, C. (2016). The Common Gut Microbe Eubacterium hallii also Contributes to Intestinal Propionate Formation. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.00713"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40168-021-01088-9","article-title":"Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice","volume":"9","author":"Zheng","year":"2021","journal-title":"Microbiome"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.7150\/thno.76002","article-title":"Commensal gut microbiota-derived acetate and propionate enhance heart adaptation in response to cardiac pressure overload in mice","volume":"12","author":"Lin","year":"2022","journal-title":"Theranostics"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Shang, H., Sun, J., and Chen, Y.Q. (2016). Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154373"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1007\/s00253-014-5829-x","article-title":"Clostridium butyricum reduce lipogenesis through bacterial wall components and butyrate","volume":"98","author":"Zhao","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_199","first-page":"2695","article-title":"Roseburia intestinalis-derived flagellin ameliorates colitis by targeting miR-223-3p-mediated activation of NLRP3 inflammasome and pyroptosis","volume":"22","author":"Wu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1038\/s41598-017-07335-0","article-title":"Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice","volume":"7","author":"Jia","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2013.10.002","article-title":"Probiotics, gut microbiota and health","volume":"44","author":"Butel","year":"2014","journal-title":"Med. Mal. Infect."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e00770-17","DOI":"10.1128\/mBio.00770-17","article-title":"Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B12 Production by Intestinal Symbionts","volume":"8","author":"Belzer","year":"2017","journal-title":"mBio"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"He, H., Xu, H., Xu, J., Zhao, H., Lin, Q., Zhou, Y., and Nie, Y. (2020). Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice. Front. Nutr., 7.","DOI":"10.3389\/fnut.2020.604283"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"e02706-19","DOI":"10.1128\/AEM.02706-19","article-title":"The Impact of pH on Clostridioides difficile Sporulation and Physiology","volume":"86","author":"Wetzel","year":"2020","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/7\/812\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:12:35Z","timestamp":1783051955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/7\/812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":204,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["antiox15070812"],"URL":"https:\/\/doi.org\/10.3390\/antiox15070812","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}